Clinical Trial

ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this project is to examine the feasibility/acceptability of a one-day Acceptance and Commitment Therapy + Lifestyle Education group intervention paired with 12-weeks of Continuous Glucose Monitoring for patients with type 2 diabetes (T2D) living in rural communities. This study is being designed as a randomized control trial (RCT) comparing ACT+LE+CGM to LE+CGM to LE. The ultimate goal of this line of research is that a community-wide intervention of Acceptance and Commitment Therapy (ACT) with Continuous Glucose Monitoring (CGM) and Lifestyle Education (LE) will improve T2D outcomes in rural communities compared to CGM and LE, or LE alone. Our goal is to develop a scalable and sustainable program for diabetes management in rural areas that enables individual self-management and does not require extensive healthcare resources in an existing medical desert.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-09-05; most recent amendment 2025-05-12.
Status change: Not Yet Recruiting → Recruiting 2024-04-17
Trial Details
NCT Number NCT06028503
Lead Sponsor Sam Houston State University
Collaborators: Chelsea Ratcliff, Ph.D., Owen Kelly, Ph.D.,RNutr, Oluwaseun Olaiya, DO, Michael Griffin, Ph.D.
Conditions Type 2 Diabetes
Enrollment 60 participants
Start Date 2024-04-01
Primary Completion 2026-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-15